ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
k141_132874_27 # 34844 # 37942 # 1 # ID=31_27;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.644	k141_132874_27	34844	37942	+	Strict	750	786.563	adeF	42.39	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAATTCGGATACTTTCATCGACCATCCTTACCTCGCGGTCGTGATCGCGATCGTGATTTCGCTGGTGGGAGCACTGGCGATCTTCGCGCTGCCGGTCGCACAGTATCCGAATGTGACGCCGCCGCAGGTCAGCATCACCACCACCTACCCCGGAGCGAGCGCGCAGGAGCTGCTCGACAGCGTGATCGAGCCGATCGAAACGCAGGTCAACGGCGTGCGCGACCTGATCTACCTCTCCTCGACCGGTTCCAACTCCGGTTCGGTCAGCATCACCGCGACCTTCCGGATCGGCTCCGACGGCCGCGCCAACACGCAGGATACGCAGGACCGGGTGAACTGGGCGCTGCCGCAGCTGCCCGAAACCGTGCAGCGCGAGGGCGTGATCGTGCAGGAACAGTCCGGCAATATCTTAATGGCGATGACCCTCTACTCGCCGAACCGCAGCTATGATACGCTGTTCCTGAGCAACTACGCGACGATCCAGCTGAAAAACCGGCTGAGCCGGATTCCGGGAGTCGCGAACATCCAGATTTTCGGCGGCAGCGACTACGCGATGCGCTTCTGGCTGGACACCGACAAGCTCGCCGCGATGAACCTGCCGGTCAGCGAAGTGGTGCGGGCGGTGCAGAATCAGAACCTGCTGGTCTCCTCCGGCGCCGTCGGTGCGGCTCCGAACCTGCCCGGCGAACCGTTGAAATACACGGTGCGCACCCGGGGACGCCTGACAGATCCGGCGCAGTTCCGCGACATCGTGGTGCGCAGCACACCCGGCGGTCCGCAGGTCAGGCTCGGCGACGTCGCCCGGATCGAGCTCGGCGGCGAAAGCTACTCCACCGCCGCCTCGCTGAACAACCAGCCCGCCGTGATGCTGCTGGTCTACCAGCAGAGCGACGCGAACGGCATCGCGATTTCGGATGCGTGCCGCGCCGCGATCGCCGAGCTGTCGCAATCGTTTCCACCCGACCTCGCGTGCGGCTTTCAGTATGATTCGACCGAATTCATCCGCGCTTCGGTCCGCGATGTGGCGGTCACGCTGGCGACCGCCGTCGCGCTGGTCGCGCTGGTCACGCTGCTTTTCCTGCAGAACTGGCGCATGGCGCTGGTGCCGACGCTGGCGATTCCGGTCAGCATCCTCGGCGCCTTCGCCGGGCTGCGGCTGCTCGGATATTCGATCAACATGGTGACTCTTTTCGGCCTTGTGCTGGCGATCGGGATTGTGGTGGACGACGCGATCATCGTGATCGAAAACGTGCACCGGCTGATGGTCGAAGAAAAGCTCGCCCCCCGCGAAGCCGCCTCCAAGTCGATGCGGCAGATCACCGGCGCGATCATCGCGACCACGCTGGTGCTGCTGGCGATGTTCGTGCCGATCTGCTTTCTCTCCGGCATCACCGGCGAGCTTTACCGGCAGTTTGGCGTGACCATCTCGACTGCGGTGCTGCTGTCGGCGGTGAACGCGCTGACGCTGAGTCCGGCGCTGGCGGCGCTGCTGCTGAAGCCGGATATGGTTGAAAGCCGGTTCTTCCTGTTCCGCTGGTTCAATGCGGGCTTCGGCGCGATCTCGAAGCGCTACGGCGGCGGCGTTGCCGCCGCGGTGCGGCGGGTTTTGCCGGTGCTGGCGGTCTACCTCGTGCTGACGGGGGCGGCGGTATGGACGTTCCACCGGGTTCCCGGCGGCTTCATCCCGGAGGAGGATCAGGGGGTATTCTTCGCCGGAATCCGGCTGCCGCCCGGTTCCTCGCTGGAGCGGACTGAGGAGAAGGTCGCGGAGCTTTCGGCTATCTTCAAAAAGCTGCCCGGCGTGCGCGACGTATTGGCCGCTCCCGGCTTCAATATCCTGAACCGCACCCCCGCCGCGAACAACGCGTTCCTGGTGGTGGTGCTCGAACCGTGGGACCGGAGGCTGAAGCGCGGCCTCTCCGCCGCGAAGCTGGTCAGGGAGGCGGAGCGGGCTTCGTTTCTGGTGCCGGAGGCGTTCACGATGGTGTTCGAGCCGCCGCCGATTCCTGGAATCGGCACGGCGGGCGGTTTCAATTTCGTGCTGGAAAACACCGCCGGCTCCGATCCCGACGCGCTCGGCGCGGCGCTTGATGCGATGCTGGAAGAGGTGATGGCAAATCCGAAATTCACCAATGTCTTCACCACCTTCAACCTGAACTGCCCCTACCTGAAACTGGAGATCGACCGGGAAAAGGCCCTGCGGCTCGGCGTGGATCTGCAGTCGATCTACTCGACGCTGGAAGGCACGCTCGGCGTCAACTACATCAATGACTTCAACCGCTTCGGACAGGTGTACAAGGTGGAGCTTCAGGCCGAACCGGGGGCGCGCGATACCATGGAGAAGATCCGCCGCCTCCACGTGCCCGGTTCCGGCAATACGATGGTGCCGCTGGATTCACTGATCAGGCTCTCGCTCCATACCGCGCCGGAATTCCTGAGCCGCTACAACCTCTTTCTGTCGGCGGAACTGCAGGGCAGTCCGGCGCCGGGCGTCAGTTCCGGCGAAGCACTGTCCGAACTTGAAGCGATCGCCGCGCGGACGCTGCCGCCCGGCATCGATCACGCCTGGACCGACATGTCCTACCAGCAGAAGCTCGCGGGCAATCAGGCGCTGCCGGTTTTCGCGCTGGCGCTGCTGTTCATCTATCTCTTTTTGGCGGCGCTGTATGAGAGCTGGGTGCTGCCGTTTTCGGTGATCCTTGCGGTGTTTCCGTCGCTGCTCGGCGCGGCCGCGCTGCTGACGCTGACCGGGATCGCCGACAACATCTACACGCAGATCGGCGTGGTGCTGCTGTTTGCAATGTCCTGCAAAAGCTCGATCCTGATCGTGGATTTCGCGCTGCAGCGCAGCCGGGAGGGAGCCGACGCTTCCGCGGCGGCGGTGGAAGCCGCCAAGCTGCGGTTCCGCGCGATCGTGATGACCGGGGCCGCTTTCGTACTTGGGACGCTGCCGCTGCTGTATGCATCCGGACCGGGGGCGGCGAGTCAGCGTTCGATCGGCGCGGCGGTGGTGGGCGGCATGACTTGTGCGGTGCTTTTCGGCGTGTTTCTGGTGCCGGTGTTCTATCGGATCTGTCGAAGGGGAGCCGGCGGCTGA	MNSDTFIDHPYLAVVIAIVISLVGALAIFALPVAQYPNVTPPQVSITTTYPGASAQELLDSVIEPIETQVNGVRDLIYLSSTGSNSGSVSITATFRIGSDGRANTQDTQDRVNWALPQLPETVQREGVIVQEQSGNILMAMTLYSPNRSYDTLFLSNYATIQLKNRLSRIPGVANIQIFGGSDYAMRFWLDTDKLAAMNLPVSEVVRAVQNQNLLVSSGAVGAAPNLPGEPLKYTVRTRGRLTDPAQFRDIVVRSTPGGPQVRLGDVARIELGGESYSTAASLNNQPAVMLLVYQQSDANGIAISDACRAAIAELSQSFPPDLACGFQYDSTEFIRASVRDVAVTLATAVALVALVTLLFLQNWRMALVPTLAIPVSILGAFAGLRLLGYSINMVTLFGLVLAIGIVVDDAIIVIENVHRLMVEEKLAPREAASKSMRQITGAIIATTLVLLAMFVPICFLSGITGELYRQFGVTISTAVLLSAVNALTLSPALAALLLKPDMVESRFFLFRWFNAGFGAISKRYGGGVAAAVRRVLPVLAVYLVLTGAAVWTFHRVPGGFIPEEDQGVFFAGIRLPPGSSLERTEEKVAELSAIFKKLPGVRDVLAAPGFNILNRTPAANNAFLVVVLEPWDRRLKRGLSAAKLVREAERASFLVPEAFTMVFEPPPIPGIGTAGGFNFVLENTAGSDPDALGAALDAMLEEVMANPKFTNVFTTFNLNCPYLKLEIDREKALRLGVDLQSIYSTLEGTLGVNYINDFNRFGQVYKVELQAEPGARDTMEKIRRLHVPGSGNTMVPLDSLIRLSLHTAPEFLSRYNLFLSAELQGSPAPGVSSGEALSELEAIAARTLPPGIDHAWTDMSYQQKLAGNQALPVFALALLFIYLFLAALYESWVLPFSVILAVFPSLLGAAALLTLTGIADNIYTQIGVVLLFAMSCKSSILIVDFALQRSREGADASAAAVEAAKLRFRAIVMTGAAFVLGTLPLLYASGPGAASQRSIGAAVVGGMTCAVLFGVFLVPVFYRICRRGAGG	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	97.45	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_45397_41 # 44997 # 48200 # 1 # ID=76_41;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.617	k141_45397_41	44997	48200	+	Strict	750	805.823	adeF	42.65	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATCAGCCGTTTTTTCATCGAGCGGCCGCGGTTCGCCTTCGTGATCTCGATCGTGATCACGCTGGCCGGACTGATTTCGATCTTCACGCTGCCGGTCGCGCAGTACCCGAACATCACGCCGTCGCTGATTTCGGTGACCACCACCTATCCGGGCGCCGACGCCAAAACCGTGCAGGAGACGGTAATCCAGCCGATCGAAGCGCAGCTCAACGGCGTGAAGCGGATGCTCTACATCAGCAGCACCGCCACCGACACCGGCATGGCCACGATCAACGTGACCTTCGACATCGGCACCGACGGCGACCAGAACACCGTGAACACCCAGAACCGGGTCAACTGGGCCAGCGCCCAGATGCCCGAGGAGGTGCGCCGCCAGAGCGTGATCGTAAAGGAGAAATCCAGCAATATGCTGCAGGTGATCGCGCTCTATTCCCCCAAAGGGACCTATGACTCATTGTTCCTGAACAACTACAGTTCGATCAACCTCAAAGATGAGCTTGCGCGCATTCCGGGCGTCGGCGACGTGCAGATGCTCGGCGAACTCAAGTATTCGATGCGAATCTGGCTGGATTCGGACAAGCTCGCCTACCTCAATATGACCGTGGATGACGTGATCGCTGCAATCAAGGCGCAGAACGTGCAGGTTTCGGCCGGAGCGCTTGGAGACGCGCCGATCTCCGGCAAGCAGGTGTTCCGCTATTCGCTGCAGACGCAGGGGCGGTTCACCGAGCCGAAGGAATTTGAAAATATCGTGGTCCGTTCCACCAGTGCCGGGGAACAGGTGCGGCTGCGCGATATCGCGAAGGTCGAACTCGGCGCCGAAAACTACTCCTCCAGCGGCAGCTTCAACGGCAAGCCCGCCGCGCTGCTCGCGATCTACCAGCTCAACGACGCGAACGGCCTCGAAATCGCCGAAGCCGCCCGGAAAAAGCTCGAAGAACTGAAGGTCTACTTCCCGGAAGACCTCGACTATGCGATCCCGTTCGACATGACCGACTTCATCACCGCCTCGATCGACGAAGTGGTGGTCACGCTGATCGAAGCGGTGCTGCTGGTGATCTTGATCACCTATCTCTTTCTGCAGGACTGGCGTTCGACGATGGTGCCGACCATCGCGATTCCGGTATCGCTGATCGGCACGTTCGCAGTGATGGCGGTGATCGGGTATTCGATCAACCTGATCACGCTCTTCGGGCTGATCCTCGCGATCGGCGTGGTGGTGGACGACGCGATCGTGGTGATCGAAAACGTGAACCGGCTGATGGAGGAGGAGCACCTCGATCCCAAAGCCGCCGCGATCAAATCGATGGAGCAGGTCACCGGGCCGGTGATCGCGACCACGCTGGTGCTGCTGGCGATGTTCATCCCGGTCTGTTTCCTGCCGGGGATCACCGGTGAAATGTACCGCCAGTTCGGCATCACCATCTCGGTGGCGGTCGCGATTTCGAGCGTCAACGCGCTGACGCTGAGTCCGGCGCTGAGCGCGATGATCCTGCGGCCGATCGATCCGAATGCGAAGAAATTCATCTTTTTCCGCTGGTTCGACGCCGGTTTCGAGAAGCTGACCGCGGGCTACGGCAAAATCGTGTCGCCGATCGTGCGGCGCACTTCGCTGATGATCGTCTGCTATGCGGGTCTGGCGTTCCTGTGCGTGCAGCTCTTCAACCATCTGCCGACCGGCTTCATCCCGGACGAAGATCAGGGCAAGCTCTTCGTAAACGTCCAGCTCCCCGACGCGGCCAGTTTGAACCGCACCACCGCCGTGACCGACCGGGCCGCGAAGCTGGCCGCCGAAGTCCCCGGCGTGATCGACGTGATCGCGGTGCCCGGCTTCAGCATCCTGACCGGCGCGCAGGCCTCCAACAACGCGCTGCTGATCGTCTGCCTGAAACCGTGGGAGGAACGCAAAAAGCCGGAGCTTCAGCAGAATGCGATCCTCGCGGAGCTGATGGCGGAATTCAATGCGATCCCCGAAGCGCAGCTCAGCGTTTTCGGCATGCCGTCGATCCAGGGGATCGGCACCACCGGGGGCTTCTCCTTCGTGATCGAGGACACCACCGGCACCCACACCGACCGGCTGCAGGAGGCGATCGACCTGATCACCGCCGAAGCGCGCAAGCGCCCGGAGTTCCTCGCGGTCTATTCGACCTTCAGCGCCAACGTGCCGCAGGTTTTCCTTGAAATCGACCGGGAAAAGGCGCTCAAGCTCGGCGTCGCGCTGACCGACCTCAACACCGCGCTGCAGGGGCTGACCGGCTACACCTACGTGAACGACTTCAACAAATACGGCAAGGTGTACAAAGTGGAAATTCAGGCCGAAACCAACTTCCGCGACAGCACCGCCAAGCTGCGCAACCTTTTCGTGCGCAATAAATCCGGCGAAATGATCCCGCTCGGCACGCTGGTCAACATCAGAACCCGCCCCTCGCCGCAATACCTGAACCGCTACAACCTCTACTCCTCGGCCACCGTCAACGGCATGCAGCGCCCCGGCTACAGCAGCGGACAGGCGATGAAGGCGATGGAGGAGATCGCCCGCAAGGTGCTGCCCGCCGGAATGAAGTTCGAATGGACCGACATGTCCTATCAGGAGCAGAAGTCCGCCGCCGGCATCAGCCTCGGCAGCATTGAAATCAATATGATGGCGGTCATCTTCGCGCTGGCGCTGCTCTTCATGTACCTCTTTCTGGTCGCGCAGTACGAAAGCTGGATGCTGCCGGTCGCGGTGCTGCTGGCGGTGCCGATCGCATTCTTCGGCTCGCTGCTGTCGCTCTACCTGGCCGGAATCGACAACAACATCTACACGCAGGTCGGCTTTGTGCTGCTTTTCGGCATCGCCTGCAAGACCGCGATCCTGATCGTGGAATTCGCCAAAAACAAATACGACGAGGGAACGCCGCTGTACGACGCGGCGCTCGCCGCCGCCAGACTGCGCTTCCGCGCGGTGCTGATGACCGCGATCTCGTTCCTGCTCGGCACGCTGCCGCTGGTGATCGCGACCGGGGCCGGAGCGGCCAGCCGCCGCTCGCTCGGCACGGCGGTGTTCGGCGGCATGTTCGTCGCGGTGATCGGCGGCACCATCCTGATCCCGGCCTTCTACGTGCTGGTGCAGCGGCTGGTCAACTGGACCGGCGGGACAGGATCGCCGCGCCGAGCGCCGCAGTCAGCGGAGCCACCAGCACCAGCCCGAAACTCCCGATGA	MISRFFIERPRFAFVISIVITLAGLISIFTLPVAQYPNITPSLISVTTTYPGADAKTVQETVIQPIEAQLNGVKRMLYISSTATDTGMATINVTFDIGTDGDQNTVNTQNRVNWASAQMPEEVRRQSVIVKEKSSNMLQVIALYSPKGTYDSLFLNNYSSINLKDELARIPGVGDVQMLGELKYSMRIWLDSDKLAYLNMTVDDVIAAIKAQNVQVSAGALGDAPISGKQVFRYSLQTQGRFTEPKEFENIVVRSTSAGEQVRLRDIAKVELGAENYSSSGSFNGKPAALLAIYQLNDANGLEIAEAARKKLEELKVYFPEDLDYAIPFDMTDFITASIDEVVVTLIEAVLLVILITYLFLQDWRSTMVPTIAIPVSLIGTFAVMAVIGYSINLITLFGLILAIGVVVDDAIVVIENVNRLMEEEHLDPKAAAIKSMEQVTGPVIATTLVLLAMFIPVCFLPGITGEMYRQFGITISVAVAISSVNALTLSPALSAMILRPIDPNAKKFIFFRWFDAGFEKLTAGYGKIVSPIVRRTSLMIVCYAGLAFLCVQLFNHLPTGFIPDEDQGKLFVNVQLPDAASLNRTTAVTDRAAKLAAEVPGVIDVIAVPGFSILTGAQASNNALLIVCLKPWEERKKPELQQNAILAELMAEFNAIPEAQLSVFGMPSIQGIGTTGGFSFVIEDTTGTHTDRLQEAIDLITAEARKRPEFLAVYSTFSANVPQVFLEIDREKALKLGVALTDLNTALQGLTGYTYVNDFNKYGKVYKVEIQAETNFRDSTAKLRNLFVRNKSGEMIPLGTLVNIRTRPSPQYLNRYNLYSSATVNGMQRPGYSSGQAMKAMEEIARKVLPAGMKFEWTDMSYQEQKSAAGISLGSIEINMMAVIFALALLFMYLFLVAQYESWMLPVAVLLAVPIAFFGSLLSLYLAGIDNNIYTQVGFVLLFGIACKTAILIVEFAKNKYDEGTPLYDAALAAARLRFRAVLMTAISFLLGTLPLVIATGAGAASRRSLGTAVFGGMFVAVIGGTILIPAFYVLVQRLVNWTGGTGSPRRAPQSAEPPAPARNSR	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	100.76	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_45410_2 # 1271 # 1378 # -1 # ID=77_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.426	k141_45410_2 	1271	1378	-	Strict	535	19.631	aadA10	100.0	3004692	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGGATATTTCCCCCGGTATCAAGATGTATTTCAAACGGTTCGAGGATTTCTTCAATCCTCAAGGAGGAGAGTTTTCCGTGCTTTTTTTCCACCACTCAATCGCCTGA	MDISPGIKMYFKRFEDFFNPQGGEFSVLFFHHSIA	MRNTVPAEISVQLSQALNVIEHHLGSTLLAMHLYGSALDGGLKPYSDIDLLVTVTARLDESVRQALFVDLLGVSVFPGQSRVLRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKARQHSLALAGSAAEDFFNPVPESDLFKALADTLKLWNSQPDWIGDERNVVLTLSRIWYSAATGKIAPKDVAANWVMERLPVQHQPVLLEARQAYLGQGEDCLASLTDQLEAFVHFVKHEATKLLGATPMMSKTKLDALST	12.64	gnl|BL_ORD_ID|2306|hsp_num:0	3398	True	loose hit with at least 95 percent identity pushed strict
